Somaxon Pharmaceuticals, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Somaxon Pharmaceuticals, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Somaxon Pharmaceuticals, Inc.. The Company's principal activity is that of licensing, development and commercialization of proprietary branded products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Its product candidates are Silenor is in Phase 3 clinical trials for the treatment of insomnia, Nalmefene hydrochloride is in a Phase 2/3 clinical trial for the treatment of pathological gambling and a Phase 2 clinical trial for smoking cessation. The Company is also developing a new formulation of Acamprosate Calcium for the treatment of certain movement disorders.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report